Bayesian

[키워드] 1:1 95% CI acute respiratory syndrome Admission adverse event age Anakinra analysed Analysis AP-HP ARD assigned Bayesian block size blocked with C-reactive protein Care clinical clinical trial Clinicians Clinique Cohort Concentration coronavirus COVID-19 CrI cytokine determine died Effect Efficacy foundation France group hazard ratio High-flow oxygen hospital IL-1 IL-1 receptor antagonist IMPROVE Infection Inflammation intensive care intention-to-treat basis IQR less mechanical ventilation median men Mild-to-moderate Ministry of Health monitoring board multicentre nasal Non-invasive non-invasive ventilation occurred Open-label outcome oxygen participant Patient patients Pneumonia posterior probability proportion provided randomised randomised controlled trial Randomly real-time RT-PCR recruited recruitment Registered risk scale screened secure selected serum severe COVID-19 stratified survival the median the WHO Trial Two patient university usual care usual care alone usual care group Ventilation WHO-CPS with COVID-19
[DOI] 10.1016/S2213-2600(20)30556-7 PMC 바로가기 [Article Type] Randomized Controlled Trial